Formulation and immunological evaluation of novel vaccine delivery systems based on bioresorbable poly(ethylene glycol)-block-poly(lactide-co-ε- caprolactone)

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 90 B, Issue 2, 2009, Pages 832-841

  Huang, Ming Hsi ^a   Chou, Ai Hsiang ^a   Lien, Shu Pei ^a   Chen, Hsin Wei ^a   Huang, Chiung Yi ^a   Chen, Wei Wen ^a   Chong, Pele ^a   Liu, Shih Jen ^a   Leng, Chih Hsiang ^a  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Bioresorbable; Block copolymer; Immune response

Indexed keywords

BLOCK COPOLYMERS; CELL MEMBRANES; COPOLYMERIZATION; EMULSIFICATION; ETHYLENE; ETHYLENE GLYCOL; IMMUNOLOGY; POLYETHYLENE OXIDES; VACCINES;

AMPHIPHILIC; ANTIBODY TITERS; BIORESORBABLE; BIORESORBABLE POLYMERS; CAPROLACTONE; DELIVERY SYSTEMS; FINE PARTICLES; IMMUNE RESPONSE; IMMUNOGENICITY; IN-VITRO; LACTIDE; MODEL STUDY; OVALBUMIN; PHYSICO-CHEMICAL CHARACTERIZATION; RELEASE PROFILES; THERAPEUTIC VACCINES; VACCINE DELIVERY SYSTEM;

POLYETHYLENE GLYCOLS;

GAMMA INTERFERON; MACROGOL; OVALBUMIN; POLY(ETHYLENE GLYCOL)BLOCK POLY(LACTIDE CO EPSILON CAPROLACTONE); POLYLACTIC ACID; UNCLASSIFIED DRUG; VACCINE;

ANIMAL EXPERIMENT; ANTIBODY SPECIFICITY; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG DELIVERY SYSTEM; EMULSION; FEMALE; IMMUNE RESPONSE; IMMUNOGENICITY; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PARTICLE SIZE; PHYSICAL CHEMISTRY;

EID: 67749148277     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31352     Document Type: Article

References (27)

1. Guy B. The perfect mix: Recent progress in adjuvant research. Nat Rev Microbiol 2007;5:505-517. (Pubitemid 46925379)
2. McKee AS, Munks MW, Marrack P. How do adjuvants work? Important considerations for new generation adjuvants. Immunity 2007;27:687-690. (Pubitemid 350102263)
3. Pashine A, Valiante NM, Ulmer JB. Targeting the innate immune response with improved vaccine adjuvants. Nat Med 2005;11:S63-S68. (Pubitemid 40562305)
4. Singh M, O'Hagan DT. Advances in vaccine adjuvants. Nat Biotech 1999;17:1075-1081.
5. Gupta RK. Aluminum compounds as vaccine adjuvants. Adv Drug Deliv Rev 1998;32:155-172.
6. Aucouturier J, Dupuis L, Ganne V. Adjuvants designed for veterinary and human vaccines. Vaccine 2001;19:2666-2672. (Pubitemid 32234287)
7. Brancq B, Trouve G. Injectable multi-phase emulsions. U.S. Pat. No.5,424,067 (1995).
8. Dupuis M, Murphy TJ, Higgins D, Ugozzoli M, van Nest G, Ott G, McDonald DM. Dendritic cells internalize vaccine adjuvant after intramuscular injection. Cell Immunol 1998; 186:18-27. (Pubitemid 28285344)
9. Allison AC. Squalene and squalane emulsions as adjuvants. Methods 1999;19:87-93.
10. Miles AP, McClellan HA, Rausch KM, Zhu D, Whitmore MD, Singh S, Martin LB, Wu Y, Giersing BK, Stowers AW, Long CA, Saul A. Montanide® ISA 720 vaccines: Quality control of emulsions, stability of formulated antigens, and comparative immunogenicity of vaccine formulations. Vaccine 2005;23: 2530-2539.
11. Ott G, Barchfeld GL, Van Nest G. Enhancement of humoral response against human influenza vaccine with the simple submicron oil/water emulsion adjuvant MF59. Vaccine 1995; 13:1557-1562.
12. van Zuylen L, Verweij J, Sparreboom A. Role of formulation vehicles in taxane pharmacology. Invest New Drugs 2001;19: 125-141. (Pubitemid 32423718)
13. Gaucher G, Poreba M, Ravenelle F, Leroux JC. Poly(N-vinylpyrrolidone)- block-poly(D,L-lactide) as polymeric emulsifier for the preparation of biodegradable nanoparticles. J Pharm Sci 2007;96:1763-1775. (Pubitemid 47122954)
14. Jeong B, Bae YH, Lee DS, Kim SW. Biodegradable block copolymers as injectable drug-delivery systems. Nature 1997; 388:860-862. (Pubitemid 27377054)
15. Youan BBC, Jackson TL, Dickens L, Hernandez C, Owusu- Ababioa G. Protein release profiles and morphology of biodegradable microcapsules containing an oily core. J Control Release 2001;76:313-326. (Pubitemid 32913439)
16. Huang MH, Li S, Hutmacher DW, Coudane J, Vert M. Degradation characteristics of poly(ε-caprolactone)-based copolymers and blends. J Appl Polym Sci 2006;102:1681-1687. (Pubitemid 44518345)
17. Shim WS, Kim JH, Park H, Kim K, Kwon IC, Lee DS. Biodegradability and biocompatibility of a pH- and thermosensitive hydrogel formed from a sulfonamide-modified poly(e-caprolactone-co-lactide)-poly(ethylene glycol)-poly(ecaprolactone- co-lactide) block copolymer. Biomaterials 2006; 27:5178-5185. (Pubitemid 44080294)
18. Zhang Y, Wang C, Yang W, Shi B, Fu S. Tri-component diblock copolymers of poly(ethylene glycol)-poly(e-caprolactone- co-lactide): Synthesis, characterization and loading camptothecin. Colloid Polym Sci 2005;283:1246-1252. (Pubitemid 41548694)
19. Umbreit JN, Strominger JL. Relation of detergent HLB number to solubilization and stabilization of D-alanine carboxy- peptidase from Bacillus subtilis membranes. Proc Natl Acad Sci USA 1973;70:2997-3001.
20. Reddy ST, Swartz MA, Hubbell JA. Targeting dendritic cells with biomaterials: Developing the next generation of vaccines. Trends Immunol 2006;27:573-579.
21. Wang C, Ge Q, Ting D, Nguyen D, Shen HR, Chen J, Eisen HN, Heller J, Langer R, Putnam D. Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater 2004;3:190-196.
22. Yang YW, Wei AC, Shen SS. The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate-a revisit of the role of the hydrophile-lipophile balance (HLB) value. Vaccine 2005; 23:2665-2675.
23. Zhu G, Mallery SR, Schwendeman SP. Stabilization of proteins encapsulated in injectable poly (lactide-co-glycolide). Nat Biotechnol 2000;18:52-57. (Pubitemid 30041172)
24. Grayson ACR, Choi IS, Tyler BM, Wang PP, Brem H, Cima MJ, Langer R. Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater 2003;2:767-772.
25. Napoli A, Valentini M, Tirelli N, Müller M, Hubbell JA. Oxidation- responsive polymeric vesicles. Nat Mater 2004;3:183-189.
26. Newman MJ, Balusubramanian M, Todd CW. Development of adjuvant-active nonionic block copolymers. Adv Drug Deliv Rev 1998;32:199-223. (Pubitemid 28267410)
27. Todd CW, Pozzi LA, Guarnaccia JR, Balasubramanian M, Henk WG, Younger LE, Newman MJ. Development of an adjuvant- active nonionic block copolymer for use in oil-free subunit vaccines formulations. Vaccine 1997;15:564-570. (Pubitemid 27188624)